WallStSmart

Certara Inc (CERT)vsHealthEquity Inc (HQY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HealthEquity Inc generates 223% more annual revenue ($1.36B vs $421.75M). HQY leads profitability with a 17.4% profit margin vs -16.2%. HQY earns a higher WallStSmart Score of 62/100 (C+).

CERT

Avoid

31

out of 100

Grade: F

Growth: 4.0Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 5/9Altman Z: 1.63

HQY

Buy

62

out of 100

Grade: C+

Growth: 6.7Profit: 7.5Value: 6.7Quality: 7.5
Piotroski: 7/9Altman Z: 1.86
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CERTUndervalued (+54.4%)

Margin of Safety

+54.4%

Fair Value

$15.21

Current Price

$7.55

$7.66 discount

UndervaluedFair: $15.21Overvalued
HQYUndervalued (+58.5%)

Margin of Safety

+58.5%

Fair Value

$185.20

Current Price

$96.26

$88.94 discount

UndervaluedFair: $185.20Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CERT1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

HQY1 strengths · Avg: 8.0/10
Operating MarginProfitability
28.4%8/10

Strong operational efficiency at 28.4%

Areas to Watch

CERT4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
1.0%4/10

1.0% revenue growth

Altman Z-ScoreHealth
1.634/10

Distress zone — elevated risk

Market CapQuality
$1.18B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-1.5%2/10

ROE of -1.5% — below average capital efficiency

HQY2 concerns · Avg: 4.0/10
P/E RatioValuation
33.7x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.864/10

Grey zone — moderate risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CERT

The strongest argument for CERT centers on Price/Book.

Bull Case : HQY

The strongest argument for HQY centers on Operating Margin. Profitability is solid with margins at 17.4% and operating margin at 28.4%. PEG of 1.40 suggests the stock is reasonably priced for its growth.

Bear Case : CERT

The primary concerns for CERT are Revenue Growth, Altman Z-Score, Market Cap.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

CERT profiles as a turnaround stock while HQY is a mature play — different risk/reward profiles.

CERT carries more volatility with a beta of 1.41 — expect wider price swings.

HQY is growing revenue faster at 7.6% — sustainability is the question.

HQY generates stronger free cash flow (135M), providing more financial flexibility.

Bottom Line

HQY scores higher overall (62/100 vs 31/100), backed by strong 17.4% margins. CERT offers better value entry with a 54.4% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Certara Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Certara Inc. provides software products and technology services to clients for biosimulation in drug discovery, preclinical and clinical research, regulatory filings, and market access. The company is headquartered in Princeton, New Jersey.

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

Want to dig deeper into these stocks?